Tuesday 30 June 2020
Investorideas.com - Rescue CBD Launches Company, Donates CBD Oil to Help Calm Shelter Animals During July 4th Fireworks
Investorideas.com - Rescue CBD Launches Company, Donates CBD Oil to Help Calm Shelter Animals During July 4th Fireworks
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 435 (TSX: $RIV.TO) (TSXV: $RTI.V) (TSXV: $XLY.V) (NASDAQ: $NEPT) (TSX: $NEPT.TO), (NYSE: $ACB) (TSX: $ACB.TO)
Investor
Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 435 (TSX: $RIV.TO)
(TSXV: $RTI.V) (TSXV: $XLY.V) (NASDAQ: $NEPT) (TSX: $NEPT.TO), (NYSE: $ACB)
(TSX: $ACB.TO)
Delta, Kelowna, BC, June 30, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read
this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/06301RIV-RTI-XLY-NEPT-ACB.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public company announcements.
Dynaleo, the Edmonton, AB
manufacturer of premium cannabis-infused gummies, has signed a letter of intent with its first
international partner.
Dynaleo, part of Canopy Rivers' (TSX:RIV) (OTC:CNPOF) portfolio of disruptive cannabis
companies, made the announcement a week after they received their Standard
Processing License from Health Canada.
"We are pleased to have entered
into a non-binding Letter of Intent with Pantry, a premium cannabis-infused
food brand. This agreement complements our already existing relationships with
cannabis brands in Canada," says Michael Krestell, Executive Chairman.
"Pantry's focus on quality
products made with natural ingredients fits perfectly with our own commitment
to manufacturing gummies that are of the highest quality," he adds.
Based in Los Angeles, California,
Pantry was created by a group of award-winning chefs and offers a variety of
cannabis-infused food products. This is the brand's first foray into Canada.
According to the agreement, Dynaleo
will manufacture and distribute cannabis-infused vegan gummies under the Pantry
brand within the Canadian market.
"Pantry is excited to combine
our passion for creating delicious health conscious cannabis products with
Dynaleo's operational excellence. Dynaleo's facility and their state-of-the-art
equipment will help us achieve best-in-class efficiencies in the market. More
importantly, the Dynaleo team is what really inspired us. We are a people and
culture driven organization and we couldn't be more impressed with Michael
Krestell, Tom Vella and the whole Dynaleo team", says Scott Jennings, CEO
and Co-Founder of Pantry.
Production on the Pantry-branded
vegan gummies is expected to begin in later this year at Dynaleo's state of the
art, 27,000 square-foot facility, the first industrial-scale and purpose-built
high-volume cannabis edible factory in Canada.
"Dynaleo is committed to
providing innovative gummy solutions for our partners. We are uniquely
positioned, because of the proprietary nature of our high-volume factory, to
meet consumer demand for gummies in Canada," says Krestell.
Solid edible products, led by
gummies, currently comprise more than 90% of the top-selling infused products.
Deloitte estimates that Canada's edibles market is worth $1.6 billion annually,
while Arcview Market Research and BDS Analytics predict that the North American
edibles market will be worth more than $4.1 billion by 2022. A new report from
the market research firm Headset also shows an uptick in gummy purchases in
several jurisdictions since the beginning of the COVID-19 pandemic.
Radient
Technologies Inc. (TSXV: RTI) (OTCQX: RDDTF), a manufacturer of high quality
cannabinoid-based formulations and products, has received a Health Canada license amendment
for the sale of cannabis extracts, cannabis edibles and cannabis topicals. This license, which allows for the sale of
all three categories of extracted products, is a significant milestone in
commercializing the Company’s product offerings and launching its 2.0 product
portfolio. Radient is also pleased to
announce that it has entered into a manufacturing and service agreement with
Premium 5 Ltd. (“P5”) for multiple products under its brand of premium
concentrates.
“Receiving this license amendment is
a critical step in diversifying and evolving Radient’s business model through
new products and customers,” said Denis Taschuk, Chief Executive Officer, Radient
Technologies. “The sales license will give Radient the ability to leverage our
unique formulations for exciting new consumer products.”
In anticipation of receiving its
sales license, Radient has started the process of increasing its product
manufacturing and filling capabilities.
The Company will have substantial capacity for white label production of
unique 2.0 products that uses its extensive formulation library. Radient believes this will be a significant
advantage in signing further manufacturing agreements and capturing new revenue
opportunities. Over the coming month,
Radient looks forward to updating stakeholders and customers on innovative
offerings.
The partnership with P5, Canada’s
preeminent concentrate supplier, will involve multiple new product lines,
bringing P5 concentrates to market with final manufacturing completed by
Radient. Under the renewable one-year
agreement, Radient will supply distillate, and provide manufacturing services
for a minimum of 240,000 units. The
first products planned will be a live resin vape cartridge, along with a live
resin X cartridge that will be blended with Radient’s THC distillate.
Premium 5 is Canada’s leader in
bringing quality concentrate products and curated devices to market. P5
launched the first live resin concentrates in the country and has quickly
become synonymous with the highest levels of quality and cutting-edge products.
Auxly
Cannabis Group Inc. (TSXV: XLY)
, a consumer packaged goods company in the cannabis products market, announced that its wholly owned subsidiary,
Dosecann LD Inc. has received its Cannabis Research Licence from Health Canada
pursuant to the Cannabis Act. This
licence permits Dosecann to administer cannabis extracts, edible cannabis and
cannabis topicals to human subjects for purposes of palatability and sensory
testing at its state-of-the-art facility located in Charlottetown, Prince
Edward Island.
Dosecann has spent the last few
years developing highly accurate, proprietary processes in order to create the
Company’s first-class suite of cannabis products, however, due to regulatory
restrictions, the product development team was unable to fully evaluate the
impact of cannabis infusion on the taste of its edible products. With this
licence, Dosecann can now conduct broader in-house testing, incorporating
consumer input and feedback on attributes such as flavour, aroma, texture or
mouthfeel, to better evaluate later-stage product formulations.
“Up until now, our team of product developers
at Dosecann knew we had great tasting non-infused formulations, but we were
unable to assess the impact of the addition of cannabis extracts. For food
product developers, it is critical that we have the ability to quickly evaluate
different product attributes; a tool that wasn’t available to us until now,”
said Peter Crooks, Chief Product Innovation Officer, Dosecann. “We will very
quickly begin to apply the ability, under this research licence, to conduct
organoleptic assessments in order to evaluate the impact of different cannabis
extracts on our edible formulations. Having this ability to conduct in-house
testing will lead to better tasting products for our consumers, generate
additional proprietary knowledge into our approach to flavour development,
processing and manufacturing, and support the optimization of the cannabis
extracts used in our different edible product segments.”
Hugo Alves, CEO of Auxly added:
“This is a key license for Auxly’s product innovation strategy and our efforts
to develop incredible cannabis products that deliver on a consumer promise of
quality, safety and efficacy. The incorporation of consumer input and feedback
during product development is critical to those efforts and has been
demonstrated repeatedly to reduce costs and time to market and increase product
acceptance by consumers. Peter and his team at Dosecann now have all of the
tools they need to innovate and delight consumers with new and exciting
cannabis products, all accurately dosed and manufactured to Dosecann’s exacting
standards.”
Neptune
Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated
health and wellness company, announced that it has been authorized by
Health Canada to sell cannabis products to provinces and territories. This
sales license includes edibles, vapes, extracts, and topicals, including
beverage products to name a few. This authorization adds to previously held
processing license and will expand Neptune's cannabis operations to include
proprietary branded products. Additionally, the authorization enhances the
capabilities of the Company's white label offerings, providing incremental
value and service offerings to its B2B customers.
In addition to the sales license,
Neptune's cold storage and added operating space have been approved for
operation. The enlarged cold storage and approved space in the Sherbooke
facility provide greater capacity to process larger volumes of product and
store at low temperature to protect product. The increased storage adds
significantly to Neptune's logistic capabilities and provides incremental
solutions to the Company's clients.
"The receipt of our sales
license is a major milestone for Neptune and significantly expands our cannabis
revenue opportunities. We are already advanced in our development of our own
brands, and look forward to announcing new branded products. We also see
potential for future co-branded opportunities. Additionally, the license
enhances our white label business, allowing us to ship direct to provincial
customers on behalf of our partners. We plan to further enhance our production
capabilities to expand both our branded and white label product solutions and
product forms and capture incremental value within the growing Canadian
cannabis market," said Michael Cammarata, Chief Executive Officer of
Neptune Wellness Solutions. "The
sales license, along with our approval to begin operating our expanded space
and cold storage significantly increase our capabilities to support our
customers, solve the storage limitation inherent among many current and
potential cannabis customers and provide significantly higher value to our
partners and customers, capturing incremental revenue and growth."
Aurora
Cannabis Inc. (NYSE: ACB) (TSX: ACB), the Canadian company defining the
future of cannabinoids worldwide, announced yesterday that Co-Founder Terry
Booth has retired from his role as Director of the Company, effective June 26,
2020. Mr. Booth was the Chief Executive Officer of Aurora from December 2014
through February 2020 and served on Aurora's Board of Directors since December
2014.
"On behalf of our Board of
Directors and management team, I would like to thank Terry for his leadership
over the years and for his tenure as a director," said Michael Singer,
Executive Chairman and Interim CEO of Aurora. "As one of the original cannabis
visionaries, Terry leaves an enviable legacy in the form of Aurora Cannabis. He
helped set the table for the Company to lead in Canada and globally, and we
continue to execute our plan to do so profitably."
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
Monday 29 June 2020
Investorideas.com - Cannabis Stock News: Aurora Cannabis (NYSE: $ACB) (TSX: ACB) Announces Retirement of Terry Booth from Board of Directors
Investorideas.com - Cannabis Stock News: Aurora Cannabis (NYSE: $ACB) (TSX: ACB) Announces Retirement of Terry Booth from Board of Directors
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Friday 26 June 2020
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstrating Safety and Skin Tolerance of Its CBD Derma Cosmetic Line
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstrating Safety and Skin Tolerance of Its CBD Derma Cosmetic Line
www.investorideas.com - news that inspires big ideas
www.investorideas.com - news that inspires big ideas
Thursday 25 June 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 434 (TSX: $WEED.TO) (NYSE: $CGC)(CSE: $ACTG_U.C)(TSXV: $KHRN.V) (OTC: $OWPC) (TSXV: $WMD.V) (OTC: $PHOT)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 434 (TSX: $WEED.TO)
(NYSE: $CGC)(CSE: $ACTG_U.C)(TSXV: $KHRN.V) (OTC: $OWPC) (TSXV: $WMD.V) (OTC: $PHOT)
Delta, Kelowna, BC, June 25, 2020 (Investorideas.com Newswire) www.Investorideas.com,
a global news source covering leading sectors including marijuana and hemp
stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/06251WEED-CGC-ACTG-KHRN-OWPC-WMD-PHOT.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com "Potcast"
featuring cannabis news, stocks to watch as well as insights from thought
leaders and experts.
In
today’s podcast we look at a few public company announcements.
Canopy
Growth Corporation (TSX:
WEED) (NYSE:
CGC)
and Acreage Holdings, Inc. (CSE:
ACRG.U) (OTCQX:
ACRGF) today
announced they have entered into an agreement to
amend the terms of the arrangement agreement dated April 18, 2019, as amended
on May 15, 2019, between Canopy Growth and Acreage.
Pursuant to the Arrangement
Agreement, Canopy Growth agreed to acquire all of the issued and outstanding
securities of Acreage pursuant to a plan of arrangement under the Business Corporations Act, contingent
upon the occurrence of changes in U.S. federal law to permit the general
cultivation, distribution, and possession of marijuana and subject to the
satisfaction or waiver of certain conditions to closing as set out in the
Arrangement Agreement.
Acreage and Canopy Growth entered
into the New Agreement to better align the terms of the Plan of Arrangement with
broader market and economic factors, provide Acreage shareholders with an
initial up-front payment in connection with the modification of Canopy Growth's
rights, including the extension of the term, and give Acreage shareholders the
ability to participate in upside potential upon the Triggering Event.
KEY
TRANSACTION HIGHLIGHTS & BENEFITS:
● Provides Up-Front Cash Payment. Canopy
Growth will pay Acreage shareholders and certain convertible security holders
an aggregate of US$37,500,000 (approximately US$0.30 per Existing Share
(defined below) on an as converted basis, with the final amount to be received
by each holder determined based on the number of Existing Shares into which all
of the eligible securities are convertible at the close of business on the
record date for the distribution).
● Attractive Valuation Premium. Acreage
shareholders' new Fixed Shares (defined below), each of which represents 70% of
an Existing Share, will be entitled to receive 0.3048 of a Canopy Growth Share
(defined below) for each Fixed Share held, representing a premium of
approximately 120% to the June 24, 2020 closing price of the Existing Shares
(defined below) on the Canadian Securities Exchange (the "CSE").
● Provides Potential Upside with Floating
Shares.
Acreage shareholders will be entitled to participate in the long-term value
created by Acreage, and in the U.S. cannabis industry generally, as a result of
the Floating Shares (defined below) which Canopy Growth may acquire in the
future upon the occurrence or waiver of the Triggering Event at a price based
upon the 30-day volume-weighted average trading price of the Floating Shares on
the CSE relative to the trading price of the Canopy Growth Shares on the NYSE
at that time, subject to a minimum of US$6.41 per Floating Share.
● Alignment with Economic and Financial
Market Conditions. Considering the challenging economic
environment and increasingly tighter and volatile financial market conditions,
particularly for cannabis companies, Acreage determined that the New Arrangement
represents the best available prospect that is compliant with the terms of the
Arrangement Agreement to maximize potential value for Acreage shareholders.
"The United States is going to
be a core market for Canopy Growth and this New Agreement solidifies our path
forward with Acreage," said David Klein, Chief Executive Officer of Canopy
Growth. "I am excited to bring our relationship with Acreage back to
centre stage in our U.S. strategy and look forward to a time when the laws in
the United States permit us to finalize this transaction as we march toward
bringing our exciting beverage products to the US."
Khiron
Life Sciences Corp. (TSXV:
KHRN) (OTCQX:
KHRNF) announced that it
has entered into an agreement with Nimbus Health, a leading German distributor
of medical cannabis products. Khiron
branded EU GMP medical cannabis will soon be available in Germany for
prescription by doctors and dispensation in pharmacies.
Tejinder Virk, President of Khiron
Europe, commented: "This is a major milestone for our company. Following
our recent entry into the United Kingdom, the expansion into Germany will
greatly benefit patients who still suffer from inconsistent supply. Khiron is now well positioned to service this
rapidly expanding market in Germany."
The supply of EU GMP medical
cannabis to Germany will be fully supported by the Company's global medical
education team, led by Dr. Maria Fernanda Arboleda, Khiron's International
Director for Medical Services. Dr. Arboleda is an Anesthesiologist, Pain and
Palliative Care Physician. She completed a Spine-Regional Anesthesia Fellowship
at the McGill University Health Center and a Post-Doctoral Research Fellow in
Supportive Cancer Care and Medical Cannabis, at the Department of Oncology,
McGill University, and at Santé Cannabis, a leading specialized cannabis clinic
in Canada.
Franziska Katterbach, Managing
Director & Chief Legal Officer for Khiron Europe based in Frankfurt,
commented: "Germany continues to be the European leader in medical
cannabis, with other countries observing and adapting to the German regulatory
model. The market is also differentiated with its large proportion of patient
prescriptions fully reimbursed through insurance."
One
World Pharma Inc. (OTC:
OWPC), a U.S. based, fully licensed, pure-play hemp and
cannabis ingredient producer in Colombia, announced that
the Company has commenced the selling of its characterized and registered seeds
in Colombia.
One World Pharma has executed seed
purchase agreements with three different Colombian growers and has begun
shipments of seeds already. The agreements represent sales to entities growing
both outdoor and in controlled environments.
One World Pharma previously
announced that the Colombian Agricultural Institute (ICA) has approved the
results of the seed characterization tests conducted by OWP of three
non-psychoactive genetics in two sub-regions of the country. The approval
established OWP as one of the few legal sellers of characterized hemp/CBD seeds
for the Cauca and the Andina regions of Colombia, inclusive of greater Bogota
and its surroundings. Additionally,
One World Pharma is now allowed to
sell its seeds in international markets.
“While just the beginning of our entry
into the revenue phase for One World Pharma, these agreements are a significant
benchmark in the execution of our business plan,” stated Isiah Thomas, CEO and
Vice-Chairman of One World Pharma. “Our first seed sale transactions affirm our
trusted, licensed position in the Colombian marketplace and pave the way for
future agreements and revenue.”
“We are intent on leveraging our
position and quickly moving forward to continue our growth and expansion,”
added Thomas. “The scale of our production and the expansion of our ingredient
portfolio for commercial sale are also accelerating.”
WeedMD
Inc. (TSX-V:WMD) (OTCQX:WDDMF) reported record
preliminary unaudited revenues of $12 million(1) for the three month period ended March 31, 2020. The
Company will report record sales growth representing the first full quarter of
integration with Starseed Holdings Inc. (“Starseed”) following its acquisition
in December 2019.
WeedMD will file its first quarter
2020 financial results after market on Tuesday July 14, 2020 and host a
conference call with management the following day.
“Driven by Color Cannabis brand
recognition, customer acquisition initiatives and a substantial sale of our
outdoor-cultivated biomass, our first quarter 2020 net revenues of $12 million
represents record-high sales from all channels – an increase of 325%
quarter-over-quarter,” said Angelo Tsebelis, CEO, WeedMD. “With the benefits of
our fully-integrated business model, scaled-up cultivation and production
capabilities combined with our strong distribution channels, WeedMD is uniquely
positioned for continued growth and a clear path to profitability. We are
looking forward to sharing more during our conference call in July.”
The Company will host a conference
call with management on Wednesday July 15, 2020 at 10 a.m. Eastern Time to
discuss its financial results.
The call will be hosted by Angelo
Tsebelis, CEO and Lincoln Greenidge, CFO. Management will be available for
analyst and media questions following opening remarks.
GrowLife,
Inc.
(OTC:
PHOT), one of the nation’s most recognized indoor
cultivation product and service providers, today
released the following letter from the Company’s Chief
Executive Officer, Marco Hegyi.
Dear Shareholders,
I would like to take this
opportunity to discuss some pertinent updates on what we are seeing in the
market as well as our perception of the rapidly expanding demand for consumer
CBD products. As we previously announced, GrowLife has been fully operational
throughout the COVID-19 pandemic in order to serve our customers across the
country with our leading line of hemp clones and commercial cloning products.
The spring season is a very important time for hemp farmers and with cloning
becoming more of the standard in CBD-rich hemp cultivation, it was imperative
that we meet the demand for our products without delay. I am happy to report
that our operations have continued to support the expanding demand for our
products.
I am also pleased to share that
demand for both cannabis and CBD products remains extremely high. While a delay
in FDA approval for CBD and other cannabinoid-based consumer packaged goods has
stalled further mainstream adoption, the demand for CBD products as ‘dietary
supplements’ is higher than ever. On the legal Cannabis industry side, which
was recently deemed an essential business, demand is still strong and the price
per pound has stabilized if not increased, as in Colorado where it is over
$1,000. As a result, demand for EZ-CLONE systems across the country remains
higher than ever, especially this quarter. We are so excited by these trends
and without getting into the specifics, I can share that I remain greatly
confident in GrowLife and the EZ-CLONE business, especially in the areas of
sales and operations.
On a more technical note, I wanted
to address the on-going fluctuations and pressure we are experiencing in the
market. As most people know, the market continues to see unprecedented swings
and volatility. These market conditions, paired with some unexpected selling,
has caused us to see a slide in the valuation of the company. While this is
disappointing, the fundamentals of the company remain strong. We believe the
market is undervaluing the Company based on its sales performance and we are
well positioned to continue to capitalize on the expanding CBD-rich hemp market
through our cloning equipment and proprietary hemp clone businesses. In spite of
the COVID-19 situation, we have taken the necessary precautions as an essential
business serving the demand of the industry, and continue to operate in a
healthy manner with all our employees making solid contributions. I am prouder
than ever in our team, suppliers and customers.
I look forward to sharing the results of these efforts in our upcoming
Q2 filings, which we expect to be filed on-time pending any further delays due
to the pandemic.
We will continue to update you all
as much as possible in the coming days and weeks. We appreciate our long-term
shareholders, employees, and customers for their continued belief in our
company. We hope everyone stays healthy and safe, and most importantly,
positive through these historic times.
Sincerely Yours,
Marco Hegyi
Chief Executive Officer
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
Subscribe to:
Posts (Atom)
Stocks to Watch Battling the Opioid Epidemic; Stocks Mentioned in this article: Greenlane Holdings, Inc. (NASDAQ: $GNLN), Safe Supply Streaming Co Ltd. (CSE: $SPLY.CN), Nutriband Inc. (NASDAQ: $NTRB), QuidelOrtho Corporation (Nasdaq: $QDEL), Emergent BioSolutions Inc. (NYSE: $EBS)
Stocks to Watch Battling the Opioid Epidemic ; Stocks Mentioned in this article: Greenlane Holdings, Inc. (NASDAQ: $GNLN), Safe Supply St...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...